These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34674620)

  • 1. Toxicity and Surface Modification of Dendrimers: A Critical Review.
    Kharwade R; Badole P; Mahajan N; More S
    Curr Drug Deliv; 2022; 19(4):451-465. PubMed ID: 34674620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer toxicity: Let's meet the challenge.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical and biomedical potential of surface engineered dendrimers.
    Satija J; Gupta U; Jain NK
    Crit Rev Ther Drug Carrier Syst; 2007; 24(3):257-306. PubMed ID: 17956215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring the dendrimer core for efficient gene delivery.
    Hu J; Hu K; Cheng Y
    Acta Biomater; 2016 Apr; 35():1-11. PubMed ID: 26923528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimer biocompatibility and toxicity.
    Duncan R; Izzo L
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2215-37. PubMed ID: 16297497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
    Wijagkanalan W; Kawakami S; Hashida M
    Pharm Res; 2011 Jul; 28(7):1500-19. PubMed ID: 21181549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of dendrimers toward biological application.
    Tsai HC; Imae T
    Prog Mol Biol Transl Sci; 2011; 104():101-40. PubMed ID: 22093218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.
    Pryor JB; Harper BJ; Harper SL
    Int J Nanomedicine; 2014; 9():1947-56. PubMed ID: 24790436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine-terminated dendritic polymers as promising nanoplatform for diagnostic and therapeutic agents' modification: A review.
    Delyanee M; Akbari S; Solouk A
    Eur J Med Chem; 2021 Oct; 221():113572. PubMed ID: 34087497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimers for pharmaceutical and biomedical applications.
    Yang H; Kao WJ
    J Biomater Sci Polym Ed; 2006; 17(1-2):3-19. PubMed ID: 16411595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.
    Lyu Z; Ding L; Tintaru A; Peng L
    Acc Chem Res; 2020 Dec; 53(12):2936-2949. PubMed ID: 33275845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
    Yellepeddi VK; Kumar A; Palakurthi S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-guest chemistry of dendrimer-drug complexes. 6. Fully acetylated dendrimers as biocompatible drug vehicles using dexamethasone 21-phosphate as a model drug.
    Yang K; Weng L; Cheng Y; Zhang H; Zhang J; Wu Q; Xu T
    J Phys Chem B; 2011 Mar; 115(10):2185-95. PubMed ID: 21338144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications and Limitations of Dendrimers in Biomedicine.
    Chis AA; Dobrea C; Morgovan C; Arseniu AM; Rus LL; Butuca A; Juncan AM; Totan M; Vonica-Tincu AL; Cormos G; Muntean AC; Muresan ML; Gligor FG; Frum A
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32882920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of dendrimers engineered with twenty common amino acids in gene delivery.
    Wang F; Hu K; Cheng Y
    Acta Biomater; 2016 Jan; 29():94-102. PubMed ID: 26525113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimers and their pharmaceutical applications--a review.
    Singh I; Rehni AK; Kalra R; Joshi G; Kumar M
    Pharmazie; 2008 Jul; 63(7):491-6. PubMed ID: 18717480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-engineered dendrimers with a diaminododecane core achieve efficient gene transfection and low cytotoxicity.
    Chang H; Wang H; Shao N; Wang M; Wang X; Cheng Y
    Bioconjug Chem; 2014 Feb; 25(2):342-50. PubMed ID: 24410081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.